Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATHEROSCLEROSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Associated Genes | APP, BMAL1, HIF1A, LDLR |
| Therapeutic Agents | CURCUMIN |
| KG Connections | 222 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
graph TD
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -->|"promotes"| MACROPHAGE["MACROPHAGE"]
style MACROPHAGE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -->|"promotes"| MACROPHAGES["MACROPHAGES"]
style MACROPHAGES fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -->|"causes"| ENDOTHELIAL["ENDOTHELIAL"]
style ENDOTHELIAL fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -->|"promotes"| PI3K["PI3K"]
style PI3K fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -.->|"reduces"| INFLAMMATION["INFLAMMATION"]
style INFLAMMATION fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -.->|"reduces"| LDLR["LDLR"]
style LDLR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
ATHEROSCLEROSIS["ATHEROSCLEROSIS"] -->|"expressed in"| DIABETES["DIABETES"]
style DIABETES fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
C1Q["C1Q"] -->|"associated"| ATHEROSCLEROSIS["ATHEROSCLEROSIS"]
style C1Q fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
C1QA["C1QA"] -->|"associated"| ATHEROSCLEROSIS["ATHEROSCLEROSIS"]
style C1QA fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
C1QC["C1QC"] -->|"associated"| ATHEROSCLEROSIS["ATHEROSCLEROSIS"]
style C1QC fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
MACROPHAGE_1["MACROPHAGE"] -->|"contributes to"| ATHEROSCLEROSIS["ATHEROSCLEROSIS"]
style MACROPHAGE_1 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
APOE["APOE"] -->|"associated"| ATHEROSCLEROSIS["ATHEROSCLEROSIS"]
style APOE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ATHEROSCLEROSIS fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Lipid Metabolism | regulates | pathway | 1.00 |
| Senescence | associated_with | disease | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Cholesterol | regulates | pathway | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Inflammation | causes | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Inflammation | contributes_to | disease | 1.00 |
| Lipid Metabolism | associated_with | pathway | 1.00 |
| Microrna | regulates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Cholesterol | inhibits | pathway | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Cholesterol | associated_with | pathway | 0.95 |
| Cardiovascular Morbidity And Mortality | causes | phenotype | 0.95 |
| Inflammation | implicated_in | disease | 0.95 |
| Cardiovascular Diseases | causes | disease | 0.95 |
| Vascular Remodelling | associated_with | process | 0.95 |
| Alzheimer'S Disease | risk_factor_for | disease | 0.95 |
| Cardiovascular Disease | causes | disease | 0.95 |
| Coronary Artery Disease | causes | disease | 0.90 |
| Stroke | risk_factor_for | disease | 0.90 |
| Oxidative Stress | therapeutic_target | pathway | 0.90 |
| Epigenetic | therapeutic_target | pathway | 0.90 |
| Nf-Κb | inhibits | pathway | 0.90 |
| Cholesterol | activates | pathway | 0.90 |
| Oxidative Stress | treats | pathway | 0.90 |
| Lipid Metabolism | therapeutic_target | pathway | 0.90 |
| Mtor | activates | pathway | 0.90 |
| Lipid Metabolism | activates | pathway | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| Heart Failure | causes | disease | 0.85 |
| Cardiovascular | activates | disease | 0.85 |
| Cardiovascular | associated_with | disease | 0.85 |
| Vascular Brain Injury | causes | process | 0.85 |
| Cardiovascular | therapeutic_target | disease | 0.85 |
| MACROPHAGES | activates | cell_type | 0.80 |
| Alzheimer's Disease | risk_factor_for | disease | 0.80 |
| Differentiation | implicated_in | pathway | 0.80 |
| Differentiation | regulates | pathway | 0.80 |
| Mtor | inhibits | pathway | 0.80 |
| Immune Response | therapeutic_target | pathway | 0.80 |
| Nf-Κb | therapeutic_target | pathway | 0.80 |
| Toll-Like Receptor | activates | pathway | 0.80 |
| Angiogenesis | regulates | pathway | 0.80 |
| Nf-Κb | regulates | pathway | 0.80 |
| Mapk | therapeutic_target | pathway | 0.80 |
| Cholesterol | therapeutic_target | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| INFLAMMATION | implicated_in | gene | 1.00 |
| OXIDATIVE STRESS | therapeutic_target | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| GENES | therapeutic_target | gene | 1.00 |
| INFLAMMATION | associated_with | gene | 1.00 |
| NF-ΚB | inhibits | gene | 1.00 |
| APOE | inhibits | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| GENES | regulates | gene | 1.00 |
| Aging | associated_with | disease | 1.00 |
| APOE | activates | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| AGING | associated_with | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| MICRORNAS | regulates | gene | 1.00 |
| LDL | inhibits | gene | 1.00 |
| LDL | activates | gene | 1.00 |
| INFLAMMATION | contributes_to | gene | 1.00 |
| Cancer | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Diabetes | associated_with | disease | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| Cardiovascular | associated_with | disease | 1.00 |
| INFLAMMATION | causes | gene | 1.00 |
| AGING | activates | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| TNF | therapeutic_target | gene | 0.95 |
| Cardiac | associated_with | disease | 0.95 |
| STROKE | associated_with | gene | 0.95 |
| APRIL | inhibits | protein | 0.95 |
| Cigarette Smoking | risk_factor_for | drug | 0.95 |
| AUTOPHAGY | activates | gene | 0.95 |
| EPSIN2 | promotes | gene | 0.95 |
| AMPK | activates | gene | 0.95 |
| EPSIN1 | promotes | gene | 0.95 |
| MIRNAS | regulates | gene | 0.95 |
| GENES | associated_with | gene | 0.95 |
| Bap | associated_with | compound | 0.95 |
| C1Q | risk_factor_for | gene | 0.95 |
| Cigarette Smoking | causes | drug | 0.95 |
| GPR146 Deficiency | protects_against | phenotype | 0.95 |
| SPP1 | contributes_to | protein | 0.95 |
| NF-ΚB | therapeutic_target | gene | 0.95 |
| GENES | activates | gene | 0.95 |
| Als | inhibits | disease | 0.95 |
| Inflammation | promotes | process | 0.95 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity